Corrigendum to:

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017)

Ulf Landmesser, M. John Chapman, Jane K. Stock, Pierre Amarenco, Jill Belch, Jan Borén, Michel Farnier, Brian A. Ference, Stephan Gielen, Ian Graham, Diederick E. Grobbee, G. Kees Hovingh, Thomas F. Luscher, Massimo Piepoli, Kausik K. Ray, Erik S. Stroes, Olov Wiklund, Stephan Windecker, Jose Luis Zamorano, Fausto Pinto & 3 others Lale Tokgozoglu, Jeroen J. Bax, Alberico L. Catapano

Research output: Contribution to journalArticle

Original languageEnglish
Article numberehx648
Pages (from-to)1-1
Number of pages1
JournalEuropean Heart Journal
DOIs
Publication statusPublished - 24 Nov 2017

Cite this

Landmesser, Ulf ; Chapman, M. John ; Stock, Jane K. ; Amarenco, Pierre ; Belch, Jill ; Borén, Jan ; Farnier, Michel ; Ference, Brian A. ; Gielen, Stephan ; Graham, Ian ; Grobbee, Diederick E. ; Hovingh, G. Kees ; Luscher, Thomas F. ; Piepoli, Massimo ; Ray, Kausik K. ; Stroes, Erik S. ; Wiklund, Olov ; Windecker, Stephan ; Zamorano, Jose Luis ; Pinto, Fausto ; Tokgozoglu, Lale ; Bax, Jeroen J. ; Catapano, Alberico L. / Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017). In: European Heart Journal. 2017 ; pp. 1-1.
@article{7c8c82af022843a8890a7e3cefc0d111,
title = "Corrigendum to:: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017)",
author = "Ulf Landmesser and Chapman, {M. John} and Stock, {Jane K.} and Pierre Amarenco and Jill Belch and Jan Bor{\'e}n and Michel Farnier and Ference, {Brian A.} and Stephan Gielen and Ian Graham and Grobbee, {Diederick E.} and Hovingh, {G. Kees} and Luscher, {Thomas F.} and Massimo Piepoli and Ray, {Kausik K.} and Stroes, {Erik S.} and Olov Wiklund and Stephan Windecker and Zamorano, {Jose Luis} and Fausto Pinto and Lale Tokgozoglu and Bax, {Jeroen J.} and Catapano, {Alberico L.}",
year = "2017",
month = "11",
day = "24",
doi = "https://doi.org/10.1093/eurheartj/ehx648",
language = "English",
pages = "1--1",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",

}

Landmesser, U, Chapman, MJ, Stock, JK, Amarenco, P, Belch, J, Borén, J, Farnier, M, Ference, BA, Gielen, S, Graham, I, Grobbee, DE, Hovingh, GK, Luscher, TF, Piepoli, M, Ray, KK, Stroes, ES, Wiklund, O, Windecker, S, Zamorano, JL, Pinto, F, Tokgozoglu, L, Bax, JJ & Catapano, AL 2017, 'Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017)', European Heart Journal, pp. 1-1. https://doi.org/10.1093/eurheartj/ehx648

Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017). / Landmesser, Ulf; Chapman, M. John; Stock, Jane K.; Amarenco, Pierre; Belch, Jill; Borén, Jan; Farnier, Michel; Ference, Brian A.; Gielen, Stephan; Graham, Ian; Grobbee, Diederick E.; Hovingh, G. Kees; Luscher, Thomas F.; Piepoli, Massimo; Ray, Kausik K.; Stroes, Erik S.; Wiklund, Olov; Windecker, Stephan; Zamorano, Jose Luis; Pinto, Fausto; Tokgozoglu, Lale; Bax, Jeroen J.; Catapano, Alberico L.

In: European Heart Journal, 24.11.2017, p. 1-1.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Corrigendum to:

T2 - 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017)

AU - Landmesser, Ulf

AU - Chapman, M. John

AU - Stock, Jane K.

AU - Amarenco, Pierre

AU - Belch, Jill

AU - Borén, Jan

AU - Farnier, Michel

AU - Ference, Brian A.

AU - Gielen, Stephan

AU - Graham, Ian

AU - Grobbee, Diederick E.

AU - Hovingh, G. Kees

AU - Luscher, Thomas F.

AU - Piepoli, Massimo

AU - Ray, Kausik K.

AU - Stroes, Erik S.

AU - Wiklund, Olov

AU - Windecker, Stephan

AU - Zamorano, Jose Luis

AU - Pinto, Fausto

AU - Tokgozoglu, Lale

AU - Bax, Jeroen J.

AU - Catapano, Alberico L.

PY - 2017/11/24

Y1 - 2017/11/24

U2 - https://doi.org/10.1093/eurheartj/ehx648

DO - https://doi.org/10.1093/eurheartj/ehx648

M3 - Article

SP - 1

EP - 1

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

M1 - ehx648

ER -